Answers are grounded in this paper and cite their sources.
Postoperative bleeding remains a common complication after oral surgical procedures, often causing patient discomfort and requiring additional clinical intervention. Tranexamic acid, an antifibrinolytic agent, has been proposed as a hemostatic adjunct to reduce such bleeding.Thus, the aim was to evaluate the efficacy of tranexamic acid in controlling postoperative bleeding following oral surgical proceduresamong 50 patients who requires a minor oral surgical procedures, divided equally into a tranexamic acid group and a control group. Baseline demographic data, medical history, and coagulation profile were recorded, and postoperative bleeding was assessed at intervals immediately post-op, at 30 minutes, and on Days 1, 3, and 7. We have found that, tranexamic acid group showed significantly lower bleeding scores than the control group at all early time points (p less than 0.05), except Day 7. Bleeding episodes occurred in 16% of the tranexamic acid group versus 48% of the control group (p=0.02), and re-intervention was needed in 4% versus 24% of patients (p=0.04). No thromboembolic events were observed in either group. We ahve come to conclude that, Tranexamic acid was effective and safe in reducing postoperative bleeding after oral surgery.
No takes yet. Share an insight, caveat, or question.
Rajaram et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: